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Reasons for routine vitamin A 
supplementation in South Africa
In 2002, South Africa (SA) introduced a national routine vitamin A 
supplementation (VAS) programme, which provides 6-monthly high-
dose (200 000 IU) vitamin A (retinyl palmitate) capsules to children 
aged 12 - 59 months and 100 000 IU to children aged 6 - 11 months 
at all public health facilities.[1] This programme was introduced 
in accordance with the recommendations of the World Health 
Organization (WHO) for children living in areas where vitamin 
A deficiency (VAD) was a concern.[2] The first survey to examine 
vitamin A status in SA was conducted by the South African Vitamin 
A Consultative Group (SAVACG), which reported a 33.3% prevalence 
of low serum retinol concentrations (serum retinol <0.7 μmol/L) in 
children aged 6 - 71 months.[3] These findings influenced the decision 
to institute a VAS programme in order to address VAD, which was 
classified as being of extreme public health importance.
Subsequent to VAS implementation, public health nutrition 
researchers raised concerns about routine VAS in SA, and proposed 
reappraisal of the programme. Their disquiet centred around the right 
to information (mothers not being informed about VAS or VAD), 
safety issues, the need for monitoring and evaluation, the programme 
absorbing a lot of resources, including human resources, and the 
inappropriate targeting of under-5s, while infectious morbidity and 
mortality are more prevalent in early infancy.[4,5] Implementation of 
VAS in areas where it is not needed incurs undue costs, when the 
money could be better utilised.[6]
There were two main reasons why routine VAS was recommended 
by the WHO and the international community: as a child survival 
strategy and to reverse VAD.
The role of high-dose vitamin A capsules in reduction  
of mortality in children aged <5 years
The WHO recommendation was based on a meta-analysis of data 
from the 1980s and 1990s that showed that high-dose VAS reduced 
overall mortality by 23%.[7] However, more recent studies have 
not supported this positive effect on mortality.[8,9] A 2013 Indian 
study, a large-scale programme evaluation with over a million 
children, reported no positive impact of high-dose vitamin A 
capsules (HDVACs) on mortality.[8] Another study, conducted in 
Guinea-Bissau (2014), which was the first individually randomised 
trial of HDVACs provided during immunisation contacts, similarly 
showed no effect of HDVACs on mortality.[9]
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In accordance with World Health Organization guidelines, South Africa (SA) introduced routine periodic high-dose vitamin A 
supplementation (VAS) in 2002. These guidelines were developed after research in the 1980s and 1990s showed the efficacy of VAS in 
reducing childhood mortality. However, two recent studies in low- to middle-income countries (2013 and 2014) have shown no effect of 
high-dose VAS on mortality. Additionally, there is no clear research evidence that 6-monthly doses of vitamin A result in a sustained shift 
in serum retinol levels or reduce subclinical vitamin A deficiency. These two points should encourage SA to re-examine the validity of 
these guidelines. A long-term view of what is in the best interests of the majority of the people is needed. The short-term intervention of 
administering vitamin A capsules not only fails to improve serum retinol levels but may create dependence on a ‘technical fix’ to address 
the fundamental problem of poor nutrition, which is ultimately underpinned by poverty. It may also cause harm. Although there are those, 
some with vested interests, who will argue for continuation of the routine high-dose VAS programmes, SA policymakers and scientists need 
to evaluate the facts and be prepared to rethink this policy. There is cause for optimism: SA’s health policymakers have previously taken bold 
stands on the basis of evidence. The examples of regulation of tobacco products and taxation of sugar-sweetened beverages, ending the free 
distribution of formula milk for HIV-positive mothers and legislating against the marketing of breastmilk substitutes provide precedents. 
Here is a time yet again for decision-makers to make bold choices in the interests of the people of SA. While the cleanest choice would be 
national discontinuation of the routine VAS programme, there may be other possibilities, such as first stopping the programme in Northern 
Cape Province (where there is clear evidence of hypervitaminosis A), followed by the other provinces in time.
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Andersen et al.[10] assessed the impact of HDVACs administered 
during public health campaigns with and without vaccination. They 
reported that although administration of oral polio vaccine (OPV) 
was associated with reduced mortality (mortality rate ratio 0.81 
(0.68 - 0.95)), surprisingly, HDVACs given either with OPV or alone 
had no impact on mortality, with mortality rate ratios of 1.10 (0.82 - 
1.48) and 1.04 (0.80 - 1.35), respectively.
While it is clear that historically HDVACs have played an important 
role in several low-income countries as a child survival strategy, it is 
worth investigating why this effect no longer seems to be evident. 
Mason, Greiner and Shrimpton were instrumental (together with 
others in the International Vitamin A Consultative Group) in 
encouraging VAS programmes in populations with evidence of VAD. 
However, these same scientists have been forced by evidence and 
observations to call for a re-think of vitamin A policies.[11] As they 
point out, the mortality effect after the 1980s and 1990s was minimal 
since there had been a positive change from the previous situation 
where there were fewer vaccines and more widespread diarrhoea and 
measles (the two infections against which VAS had most effect). When 
researchers re-analysed the data from one of the original vitamin A 
trials, the Ghana Vitamin A Supplementation Trial, surprisingly, only 
children who had not received any immunisations benefited from 
the vitamin A.[12] Since then, vaccination coverage has increased, and 
the availability of new vaccines against pneumonia and diarrhoea 
has contributed to a significant reduction in morbidity and mortality 
from these. In view of the above changes, it is therefore not surprising 
that VAS no longer results in the earlier large reductions of mortality.
The role of HDVACs in reducing subclinical VAD
Although it is plausible and a widely held belief,[11] there is, however, 
no clear research evidence to support the assumption that 6-monthly 
high-dose VAS will shift serum retinol levels or reduce subclinical 
VAD (serum retinol <0.7 μmol/L). Even West et al.,[13] strong 
defenders of HDVAC programmes, admit that HDVACs do not 
correct the root problem of VAD and that better interventions would 
be dietary diversification and food fortification. Studies have shown 
that serum retinol levels rise rapidly after high-dose vitamin A 
administration, but that these levels decline within 1 - 3 months. [14,15] 
Additionally, it has been shown that food-based interventions, e.g. 
red palm oil consumption, can reverse VAD,[16] and in SA beta-
carotene-rich orange-fleshed sweet potato improved the vitamin A 
status of primary schoolchildren.[17] Food-based interventions have 
advantages over HDVACs because of the added nutritional benefit 
of the vitamin A food matrix. Indeed, in the 1990s international 
agencies always saw HDVACs as an interim emergency measure 
while encouraging dietary diversification and dietary education. 
However, even after two decades VAS is still being promoted and 
implemented by the international agencies.[18]
SA and many other low- to middle-income countries (LMICs) 
would benefit from food-based approaches, as these would result in 
general improvement in food intake with an added beneficial impact 
on malnutrition and survival.
What of the possibility of harm in 
HDVAC programmes?
As discussed above, the two tenets on which the recommendation 
for routine VAS were based (child mortality and VAD reduction) 
appear no longer to be valid. This has resulted in vigorous debate 
in the past few years,[5,11,13,19,20] with the new scientific evidence 
largely being ignored by the proponents of HDVAC. In our view, 
this is partly because many from both science and pharma have 
invested considerably in promoting HDVAC as a magic bullet against 
mortality.[21]
An additional important piece of information is that in the early 
years when high-dose VAS was introduced, there was little thought 
that these exceptionally high, non-physiological doses of vitamin 
A might actually cause harm, and that interactions with certain 
vaccines may cause harm.[22] Benn and colleagues[23,24] reported that 
HDVAC was associated with increased mortality in girls who also 
received diphtheria, pertussis and tetanus vaccine. Hypervitaminosis/
excessive vitamin A intake has been linked to adverse health 
effects. [25] We are reminded of the basic foundation of public health 
policy – ‘first do no harm’.
As more evidence emerges on the physiology and processing 
of vitamin A, it has become clear that the use of such high 
pharmacological doses of vitamin A, especially in a young child, can 
overload the liver, which may not be able to store such large quantities, 
resulting in excess vitamin A being unbound and potentially toxic to 
cells.
Many countries have also introduced successful fortification 
programmes, including SA, which commenced fortification of wheat 
flour and maize meal with vitamin A in 2003 as part of the National 
Food Fortification Programme.[26]
With such ongoing parallel fortification programmes, as well as 
improved intake of vitamin A-rich foods, there is a real possibility 
that some members of the population will in fact be consuming 
abnormally high amounts of vitamin A. A recent review, using case 
studies in the USA, Guatemala, Zambia and SA, clearly illustrated the 
potential for excessive intakes in some groups.[27] The review reported 
that in SA there are sectors of the population that regularly consume 
liver,[28] a rich source of vitamin A, and that children who received 
VAS as well as eating liver had an increased risk of hypervitaminosis 
A based on elevated serum retinyl esters. Hypervitaminosis A was 
originally described in high-income countries, where it was linked 
to over-use of over-the-counter supplements. The review,[27] however, 
showed that even in LMICs with overlapping programmes providing 
vitamin A, hypervitaminosis A may affect some populations.
A recent SA study conducted in Northern Cape Province, where 
liver is frequently eaten, measured liver vitamin A stores (using 
retinol isotope dilution) before and after a high-dose supplement in 
preschool children who consumed liver regularly and were exposed 
to VAS and fortification.[29] It showed that 64% had hypervitaminosis 
A at baseline, which increased to 72% after VAS, while no children 
had vitamin A-deficient liver stores. Liver vitamin A concentrations 
correlated significantly with the number of vitamin A supplements 
received during the past year, as well as the total number of vitamin 
A supplements received since birth.[29]
Opportunity costs of VAS 
programmes
It is recommended that HDVACs are administered with vaccina tions. 
While this occurs with routine immunisation, it is often supplemented 
by ‘child health days’ when a national campaign is conducted to 
rapidly boost coverage. Furthermore, many countries still rely solely 
on such campaigns to provide HDVACs. The opportunity cost of 
child health days is significant, especially in terms of health personnel 
who are withdrawn from their normal duties for these events, with 
consequent negative effects on other activities. These opportunity 
costs have been shown both in SA[30] and in other countries.[31,32] 
HDVAC campaigns may therefore indirectly cause harm by diverting 
attention and resources from other important activities such as 
breastfeeding promotion and food security programmes. The United 
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Nations Children’s Fund (UNICEF) in its 2018 report Coverage 
at a Crossroads: New Directions for Vitamin A Supplementation 
Programmes[18] lamented that ‘While Child Health and Nutrition 
Days are delivering vitamin A supplements in many places, in some 
countries these events have been co-financed using polio funding, 
which is now dwindling. The sustainability of VAS programmes is 
also tenuous.’ The South African Health Review also noted the low 
coverage of 54.3% in SA in 2017 - 2018.[33] However, as argued by 
some, there may not be reason to lament.[22]
Conclusion and recommendations
In summary, there is no evidence from the past two decades, with 
changing disease profiles, increased use of vaccines and reduced 
morbidity from diarrhoea and pneumonia, that a high-dose VAS 
programme is nearly as effective today as it was in some countries 
20 - 30 years ago. Furthermore, in spite of the current VAS coverage 
of 54.3%, diarrhoeal disease-related deaths showed a 70.1% decrease 
from 2005 to 2015.[33] These data imply that the deaths decreased in 
spite of stagnant and poor VAS coverage. According to the Global 
Burden of Disease 2013 estimates for SA, VAD accounted for only 
0.17% of total disability-adjusted life years (DALYs), compared with 
wasting (2.96%) and non-exclusive breastfeeding (1.73%).[34]
SA implemented VAS in 2002 based on the SAVACG findings and 
WHO guidance and without, we believe, taking into account the 
prevailing morbidity and mortality patterns.
The proponents of continuation of HDVAC programmes argue 
that discontinuing HDVAC programmes should be considered 
only when countries can report a prevalence of <5% for low serum 
retinol. [35] However, this suggestion is not supported by current 
scientific evidence that shows that HDVAC programmes do not 
prevent VAD in terms of serum retinol.[13] Using such a prevalence 
level as a cut-off would imply that almost every country in the world 
should use HDVACs, as at any given time some people will fall below 
the serum retinol cut-off owing to natural variation or as a result of 
infection, which is known to temporarily lower serum retinol levels.
We believe that there is a role for disease-targeted vitamin A, 
such as in the treatment of measles cases, severe malnutrition and 
persistent diarrhoea.[36] We do not believe that there is sufficient 
evidence to justify the continuation of the routine VAS programme 
in SA. However, constant vigilance is key in order to identify areas 
where VAD may be prevalent in the population, e.g. among the poor 
or in poorly resourced informal settlements.
Putting an end to routine high-dose VAS programmes may 
represent an inconvenient truth for many in the search for magic 
bullets to alleviate public health problems. However, Mason 
et  al. [11] highlight the potential cost-benefit of ending ineffective 
and potentially harmful HDVAC programmes. Discontinuing the 
HDVAC programme in SA will free up resources, both human and 
financial, to concentrate on intervention programmes of known 
benefit with wider and more sustained impact, viz. timely BCG 
vaccine provision,[37] breastfeeding promotion, dietary diversification, 
mentoring of community caregivers and poverty alleviation.
We need to take a long-term view of what is in the best interests 
of the majority of the people we serve. Although it may seem easier 
to just ‘pop a pill’, this intended short-term intervention not only 
fails to maintain vitamin A health but also renders populations 
dependent on a ‘technical fix’ to address the fundamental problem 
of poor nutrition, ultimately underpinned by poverty – and it may 
cause harm.
Although there are those who will argue for continuation of 
the routine high-dose VAS programmes, SA policymakers and 
scientists need to evaluate the facts and be prepared to rethink this 
policy. We have cause to be optimistic: SA’s health policymakers 
have previously taken bold stands on the basis of evidence. The 
examples of regulation of tobacco products and taxation of sugar-
sweetened beverages, ending the free distribution of formula milk 
for HIV-positive mothers, and legislating against the marketing of 
breastmilk substitutes provide precedents. Further, when the WHO 
released new guidance in 2011[38] on postpartum, neonatal and young 
infant VAS based on new evidence, and concluded that providing 
HDVACs to these groups was not to be recommended owing to 
lack of any measurable effect, SA ended these programmes. These 
same guidelines called for a review of the guidelines for HDVAC to 
children aged >6 months to be undertaken in 2016. This has not yet 
taken place. We hereby call for an urgent review of the WHO policy 
guidelines for children aged >6 months.
However, SA does not need to wait for the WHO to review its 
guidelines: here is a time yet again for decision-makers to make 
bold choices in the interests of our people. While the logistically 
easiest choice would be national discontinuation of the routine 
VAS programme, there may be other possibilities, such as first 
stopping VAS in the Northern Cape (where there is clear evidence 
of hypervitaminosis A), followed by the other provinces in time. 
Whatever decision is taken regarding the VAS programme in SA, 
monitoring and evaluation of the consequences for both VAD and 
overall mortality are essential.
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